Circulating Adipocyte Fatty Acid Binding Protein (A-FABP): Predictor of Metabolic Syndrome in Patients with Type 2DM

ADIPOCYTES FATTY ACID BINDING PROTEIN AND ITS RELATION TO SUBCLNICAL ATHEROSCLEROSIS IN SUBJECTS WITH TYPE 2 DIABETES

Relation of Serum Lipoprotein (a) and Severity of Coronary Artery Disease in Type 2 Diabetic Patients

Possible Role of Fatty Acid Binding Protein in Type 2 Diabetes and Peripheral Artery Disease: Review Article

The Relation Between Serum Chemerin Level and Atherosclerosis in Type II Diabetic Patients with and Without Coronary Artery Disease

Adiponectin in Type II Diabetes Mellitus

SERUM LEVELS OF ADIPOCYTE FATTY ACID BINDING PROTEIN 4 AND RETINOL BINDING PROTEIN 4 AS BIOMARKERS FOR EARLY DETECTION OF DIABETIC NEPHROPATHY IN TYPE 2 DIABETES

Lipoprotein (A) In Type 2 Diabetes Mellitus as A Marker of Atherosclerotic Cardiovascular Disease

Fatty Acid Binding Protein (1 & 2) as Markers of Diabetic Nephropathy in Elderly Patients with Type 2 Diabetes Mellitus

The Association between Serum Adropin Level and Metabolic Complications of Type 2 Diabetes Mellitus